The strong EPS beat and maintained guidance support the stock, but the historical calibration shows past bullish calls on MMSI have underperformed (0% win rate at T+20). The View Point Medical acquisition adds a near-term catalyst in therapeutic oncology. Monitor Q2 for integration progress and any tariff-related margin commentary.
Price Chart
Executive Summary
Merit Medical reported Q1 2026 EPS of $0.94 (non-GAAP, the Street convention), beating the $0.83 consensus by 13.3%, and revenue of $381.9M, exceeding the $377.6M estimate by 1.1%. The company maintained its full-year 2026 guidance for revenue of $1.612-$1.634B and non-GAAP EPS of $4.01-$4.15, while organic constant-currency revenue grew 3.7% excluding a divestiture.
Key Financial Metrics
Key Facts
- Non-GAAP EPS of $0.94 beat consensus of $0.83 by 13.3%
- Revenue of $381.9M beat consensus of $377.6M by 1.1%
- Revenue grew 7.5% YoY reported; constant-currency organic growth was 2.7% (3.7% ex-divestiture)
- Non-GAAP operating margin expanded to 19.7% from 19.3% YoY
- Free cash flow increased 26% YoY to $24.7M
- Full-year 2026 guidance maintained: revenue $1.612-$1.634B, non-GAAP EPS $4.01-$4.15
- Acquired View Point Medical on April 1, 2026 for $140M; expected to be margin-accretive
- Divested DualCap product line for $28M in February 2026
Financial Impact
EPS beat of $0.11 (13.3%) on consensus $0.83; revenue beat of $4.3M (1.1%) on consensus $377.6M
Risk Factors
- Tariff headwinds cited as incremental YoY pressure on margins
- View Point Medical acquisition expected to dilute 2026 non-GAAP EPS by ~$0.05
- Historical calibration shows past bullish calls on MMSI have not moved the stock as expected
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3285446 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 2, 2026 13w ago | Press Release | $71.09 $87.00 | ▲ +22.38% | ▲ +18.81% | $86.21 (+21.27%) |
May 5, 2026 21w ago | Insider Cluster | $60.44 $83.35 | ▲ +37.91% | ▲ +35.17% | $86.21 (+42.64%) |
May 5, 2026 21w ago | Insider Cluster | $60.44 $83.35 | ▲ +37.91% | ▲ +35.17% | $86.21 (+42.64%) |
Apr 30, 2026 22w ago | Press Release | $62.01 $78.29 | ▲ +26.25% | ▲ +23.18% | $86.21 (+39.03%) |
Apr 16, 2026 24w ago | Court Ruling | $70.10 $73.26 | ▲ +4.51% | ▼ −2.54% | $86.21 (+22.98%) |
Apr 13, 2026 24w ago | 8-K | $70.54 $71.46 | ▲ +1.30% | ▼ −7.22% | $86.21 (+22.21%) |
Feb 24, 2026 31w ago | 8-K | $79.23 $64.49 | ▼ −18.60% | ▼ −25.55% | $86.21 (+8.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access